By Ben Conarck ( April 27, 2015, 8:05 PM EDT) -- Impax Laboratories Inc. asked a California federal judge Friday to toss a shareholder derivative suit accusing its board of directors of allowing recurring regulatory compliance failures, saying the complaint falls short of showing a lack of board oversight or a disregard of any alleged "red flags" raised over its drug production....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.